News


  • Extremities
    KFx Medical Sues Stryker for Rotator Cuff Repair Patent Infringement

    KFx Medical Sues Stryker for Rotator Cuff Repair Patent Infringement

    KFx successfully defended these patents versus Arthrex Inc. in 2015.
    Business Wire 08.17.18

  • Spine/Neurology
    FDA OKs CoreLink

    FDA OKs CoreLink's Foundation 3D Anterior Lumbar (ALIF)

    Foundation 3D ALIF leverages CoreLink’s Mimetic Metal technology that mimics key characteristics of natural bone.
    Business Wire 08.17.18

  • Extremities | Spine/Neurology
    FDA Clears SPR Therapeutics’ Peripheral Nerve Stimulation Systems for Pain Management

    FDA Clears SPR Therapeutics’ Peripheral Nerve Stimulation Systems for Pain Management

    SPRINT, one of the cleared systems, is the first and only dual lead capable PNS platform.
    GlobeNewswire 08.16.18

  • Instruments
    Bone Index

    Bone Index's Bindex POC Osteoporosis Measurement Gains Medicare Coverage

    Bindex point-of-care device measures the cortical bone thickness of the tibia and the algorithm calculates the Density Index.
    PR Newswire 08.16.18

  • Spine/Neurology
    Former GE Executive to Lead NuVasive

    Former GE Executive to Lead NuVasive's Manufacturing Facility in Ohio

    New hire will manage the 180,000 square foot manufacturing operations and focus on optimizing output.
    NuVasive Inc. 08.16.18

  • Biologics | Bracing/Prosthetics | Extremities | Imaging | Instruments | Large Joint | MIS/Robotics | Spine/Neurology | Trauma/Sports
    2018 Top 10 Global Orthopedic Device Firms

    2018 Top 10 Global Orthopedic Device Firms

    Robotics and leadership changes defined the 2017 fiscal year among the largest orthopedic firms.
    08.15.18

  • 2018 Top 10 Global Orthopedic Device Firms

    2018 Top 10 Global Orthopedic Device Firms

    Robotics and leadership changes defined the 2017 fiscal year among the largest orthopedic firms.
    ODT Staff 08.15.18

  • 1. Stryker Corp.

    1. Stryker Corp.

    $12.4 Billion KEY EXECUTIVES: Kevin A. Lobo, Chairman and CEO Glenn S. Boehnlein, Vice President, CFO Lonny J. Carpenter, Group President and advisor to the CEO Viju Menon, Group President, Global Quality and Operations David K. Floyd, Group…
    08.15.18

  • 2. DePuy Synthes

    2. DePuy Synthes

    $9.3 Billion KEY EXECUTIVES: Alex Gorsky, Chairman and CEO Dominic J. Caruso, Exec. VP and CFO Jennifer Taubert, Company Group Chairman, Johnson & Johnson Ashley McEvoy, Exec. VP, Worldwide Chairman, Medical Devices Sandra E. Peterson, Ex…
    08.15.18

  • 3. Zimmer Biomet

    3. Zimmer Biomet

    $7.8 Billion KEY EXECUTIVES: Bryan C. Hanson, President and CEO Daniel P. Florin, Exec. VP and CFO Aure Bruneau, Group President, Spine, CMF, Thoracic and Surgery Assisting Technology David A. Nolan Jr., Group President, Biologics, Extremities…
    08.15.18

  • 4. Smith & Nephew

    4. Smith & Nephew

    $4.8 Billion KEY EXECUTIVES: Roberto Quarta, Chairman Namal Nawana, CEO Graham Baker, CFO Catheryn O’Rourke, Chief Legal Officer Rodrigo Bianchi, President, International Markets Vasant Padmanabhan, President of Research & Developm…
    08.15.18

  • 5. Medtronic (Spine Division)

    5. Medtronic (Spine Division)

    $2.6 Billion KEY EXECUTIVES: Omar Ishrak, Chairman and CEO Michael J. Coyle, Exec. VP and Group President, Cardiac and Vascular Group Hooman C. Hakami, Exec. VP and Group President, Diabetes Group Bob White, Exec. VP and Group President, Minim…
    08.15.18

  • 6. DJO Global

    6. DJO Global

    $1.2 Billion KEY EXECUTIVES: Brady R. Shirley, President, CEO, and Director Mike Eklund, CFO and COO Toby Bost, President, DJO Global Consumer Business W. Mark Dorris, President, Bracing & Supports Jeffery A. McCaulley, Global President,…
    08.15.18

  • Bracing/Prosthetics | MIS/Robotics
    Robotics Revolution

    Robotics Revolution

    In my Letter last issue, I was wondering about what had happened to the promise of smart implants. The combination of sensors, connectivity, IoT, and miniaturization could be leveraged to enhance the level of orthopedic care provided to patients requ…
    Sean Fenske, Editor-in-Chief 08.15.18

  • 7. NuVasive Inc.

    7. NuVasive Inc.

    $1 Billion KEY EXECUTIVES: Greg Lucier, Chairman and CEO Rajesh Asarpota, Exec. VP and CFO Skip Kiil, Exec. VP, Global Commercial Pete Leddy, Exec. VP, People and Culture Matt Link, Exec. VP, Strategy, Technology, and Corporate Development S…
    08.15.18

  • 8. Wright Medical

    8. Wright Medical

    $745 Million KEY EXECUTIVES: Robert J. Palmisano, President and CEO Lance A. Berry, Sr. VP and CFO Robert P. Burrows, Sr. VP, Supply Chain J. Wesley Porter, Sr. VP and Chief Compliance Officer Julie D. Tracy, Sr. VP and Chief Communications O…
    08.15.18

  • 9. Globus Medical

    9. Globus Medical

    $636 Million KEY EXECUTIVES: David C. Paul, Exec. Chairman David M. Demski, CEO Anthony L. Williams, President Daniel T. Scavilla, Sr. VP and CFO Eric Ian Schwartz, Sr. VP and General Counsel NUMBER OF EMPLOYEES: 1,500 GLOBAL HEADQUARTE…
    08.15.18

  • 10. Össur Hf

    10. Össur Hf

    $569 Million KEY EXECUTIVES: John Sigurdsson, President and CEO Sveinn Sölvason, CFO Egill Jónsson, EVP of Manufacturing and Operations Gudjon G. Karason, EVP of Clinics Margrét Lára Friðriksdóttir, EVP of…
    08.15.18

  • Effects of MEDDEV Revision 4 on Clinical Evaluation Reports (Part 2)

    Effects of MEDDEV Revision 4 on Clinical Evaluation Reports (Part 2)

    Whether writing a clinical evaluation report (CER) for a new device or updating one for an existing device, compliance with MEDDEV 2.7/1 Revision 4 requirements is integral. As part of the general planning associated with CERs, first perform a gap as…
    Jonathan Gimbel, Director, Regulatory and Quality Solutions LLC (R&Q) 08.15.18

  • Innovation in the 510(k) Space: A Case for Incrementalism

    Innovation in the 510(k) Space: A Case for Incrementalism

    Although the term “innovative technology” often evokes images of a breakthrough, radical discovery, or inventive cure-all, the certainty associated with incremental improvements to established, higher-risk technologies such as implantable…
    Samuel Pollard, Senior Regulatory Associate, Musculoskeletal Clinical Regulatory Advisors 08.15.18